Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease

Tomás González-Hernández1, Ignacio Cruz-Muros, Domingo Afonso-Oramas

  • 1Department of Anatomy, Faculty of Medicine, University of La Laguna Tenerife, Spain.

Frontiers in Neuroanatomy
|November 17, 2010
PubMed

Insights

Parkinson's disease (PD) involves the degeneration of midbrain dopaminergic (DA) neurons, a process influenced by both internal and external factors. Understanding these factors is key to addressing the differential vulnerability observed in DA-cell loss during PD progression.

Area of Science:

  • Neuroscience
  • Pathology
  • Neurodegenerative Diseases

Background:

  • The concept of "vulnerability" in midbrain dopaminergic (DA) neurons dates back to observations of neuronal loss in post-encephalitic Parkinson's disease (PD).
  • Differential degeneration patterns, particularly in the substantia nigra compacta, highlight the selective vulnerability of these DA neurons.
  • Massive loss of nigral DA neurons is a pathological hallmark of PD, directly linked to motor symptoms.

Purpose of the Study:

  • To review current knowledge on factors contributing to DA-cell degeneration in PD.
  • To explore the roles of intrinsic and extrinsic factors in the initiation and progression of DA-cell loss.
  • To discuss the differential vulnerability of midbrain DA neurons in the context of PD pathogenesis.

Main Methods:

  • Review of existing human data, cellular models, and animal models of PD.
  • Analysis of pathogenic factors, including oxidative stress, intrinsic neuronal factors, and extrinsic environmental/brain region factors.
  • Examination of the contribution of impaired cell functions (energy metabolism, proteostasis) versus specific DA functions (pacemaking, DA handling).

Main Results:

  • DA-cell degeneration in PD is a complex process influenced by multiple risk factors and oxidative stress.
  • Intrinsic factors appear crucial in the early stages of degeneration, while extrinsic factors contribute to its progression.
  • The relative importance of common cellular functions versus specific dopaminergic functions in DA-cell degeneration remains a subject of debate.

Conclusions:

  • Midbrain DA-cell degeneration in PD is multifactorial, involving a complex interplay of intrinsic and extrinsic factors.
  • Understanding the differential vulnerability of DA neurons is critical for elucidating PD pathophysiology.
  • Further research is needed to clarify the precise roles of various cellular and functional impairments in PD pathogenesis.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...